NCT05409118View on ClinicalTrials.gov

JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
AAAAAA - Abdominal Aortic Aneurysm
Interventions
DEVICE

Alto Abdominal Stent Graft System

Endovascular Abdominal Aneurysm Repair (EVAR) using commercially available, FDA approved endovascular graft systems implanted.

DEVICE

FDA Approved EVAR AAA Graft Systems

FDA approved comparator of choice

Sponsors

Lead Sponsor

Endologix
All Listed Sponsors
lead

Endologix

INDUSTRY

NCT05409118 - JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization | Biotech Hunter | Biotech Hunter